Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

NCT07227012 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Hepatocellular
Hepatocellular Cancer
Hepatocellular Carcinoma
Unresectable Hepatocellular Carcinoma
Liver Neoplasms
Advanced Hepatocellular Carcinoma
Metastatic Hepatocellular Carcinoma

Interventions

BIOLOGICAL: PF-08634404
BIOLOGICAL: Ipilimumab

Sponsor

Pfizer